Genmab A/S Statistics
NASDAQ: GMABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
36.65-1.15 (-3.04%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 35.63 -2.78%
Genmab A/S by the numbers
Genmab A/S has a market capitalization of $22.54 billion based on 614.90M shares outstanding. Its trailing P/E ratio is 29.8, above the 5-company peer median of 17.3, and its forward P/E is 24.0. The stock trades 10.9% above its 50-day average and 23.4% above its 200-day average.
Average daily trading volume is 2.78M shares, or about $101.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GMAB valuation vs. peer median
| Metric | GMAB | Peer median | Difference |
|---|---|---|---|
| Market cap | $22.54B | $22.80B | -1% |
| P/E (TTM) | 29.8 | 17.3 | +72% |
| Forward P/E | 24.0 | 17.9 | +34% |
| Avg. volume | 2.78M | 2.21M | +26% |
Peer median across 8 companies: INSM, UTHR, VTRS, ROIV, ZTS, ALNY, ASND, JAZZ.
Valuation
- Market cap
- $22.54B
- P/E (TTM)
- 29.80
- Forward P/E
- 24.03
- Price / sales (latest FY)
- 6.06
- EPS (TTM)
- $1.23
- Shares outstanding
- 614.90M
Price and trading
- Previous close
- 37.80
- Open
- 37.30
- Day range
- 36.27 – 37.86
- 52-week range
- 23.62 – 40.17
- 52-week change
- +12.29%
- Beta
- —
- Volume
- 4.25M
- Average volume
- 2.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 22.54B
- Pe
- 29.80
- Forward Pe
- 24.03
- Eps
- 1.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.17
- Week52 Low
- 23.62
- Avg Volume
- 2.78M
- Shares Outstanding
- 614.90M
- Ma50
- 33.04
- Ma200
- 29.69
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -8.76%
- Pct From52w Low
- 55.17%